Phase I Study of Tremelimumab (Trem) in Combination with Gefitinib (Gef) in Epidermal Growth Factor Receptor Mutant (Egfr-Mut) Non-Small Cell Lung Cancer (Nsclc)
作者
David Planchard,N. Chaput-Gras,Fabrice Barlési,Julien Mazières,Natalie Byrne,D. Vuillier,Ludovic Lacroix,Benjamin Besse,Émilie Lanoy,Fanny Wunder,C. Jannin,K. Malekzadeh,Maud Ngo‐Camus,Anthony Nash,Alessandra di Pietro,J.C. Soria
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2014-09-01卷期号:25: iv468-iv468被引量:1